법무법인 트리니티

KR

EN

KR

EN

KR

EN

Jason Kim

Partner

M&A, Joint Ventures, General Corporate, Corporate Governance, Capital Markets, and Insolvency and IP Transactions

김정한

Profile

Experience

Trinity Legal, Partner
Central IP & Law Group, Partner
Hanyang University, International Studies Dept., Adjunct Professor
Kim & Kim Law Office, Associate
Cadwalader, Wickersham & Taft LLP, Capital Markets, Associate
Citigroup Global Markets Inc., Commercial RE Finance

Education

Brooklyn Law School, Brooklyn, NY (Juris Doctorate, 2005)
Trinity College, Hartford, CT (Bachelor of Arts, 1999)

Qualifications

New York (Admitted 2007)
New Jersey (Admitted 2005)

Experiences

Advised a private equity client in the acquisition of a publicly listed semi-conductor company in Korea.

Advised a publicly listed Korean Company on the establishment of a Joint Venture in Europe and US.

Advised a publicly listed Korean cosmetics company in the private acquisition of a US distributor and establishment of a US local subsidiary through an asset purchase transaction.

Advised a Taiwan Fintech company on the establishment of a strategic alliance with a Korean Payment Gateway company.

Advised a publicly listed Korean company in a tri-partite Joint Venture in Korea.

Advised a Korean company in a Joint Venture in Saudi Arabia.

Advised publicly listed Korean software company on IT infrastructure and software development project.

Advised a Korean company in connection with spin-off of acquired company and exit of a PE investor.

Advised a Korean company in technology transfer agreements.

Advised a Korean company in supply contracts.

Advised on technology and IP license agreements.

Advised a Korean investor on a reverse triangular merger of a US Bio- pharmaceutical company.

Advised Woori Bank on the secured financing for a Dubai/UAE project development agreement.

Advised a Korean university on the medical research licensing agreement with GE Electronics.

Advised US Investor on the subscription of bonds with warrants of a KOSDAQ listed bio-pharmaceutical company.

Advised a publicly listed Korean company in a Joint Venture in China.

Language

English and Korean

error: